Accounts Receivable, after Allowance for Credit Loss, Current of GeoVax Labs, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: GeoVax Labs, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
GeoVax Labs, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

GeoVax Labs, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$0	-$547,574	-100%	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	$532,771	+$232,094	+77%	30 Jun 2025	10-Q	28 Jul 2025	2025	Q2
Q1 2025	$1,497,545			31 Mar 2025	10-Q	01 May 2025	2025	Q1
Q4 2024	$659,409	+$659,409		31 Dec 2024	10-Q	13 Nov 2025	2025	Q3
Q3 2024	$547,574			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$300,677			30 Jun 2024	10-Q	06 Aug 2024	2024	Q2
Q4 2023	$0			31 Dec 2023	10-K	27 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.